
    
      This biomarker study consists of a single outpatient visit to the research unit. At this
      visit, eligibility will be assessed and biomarker samples (blood, saliva and urine) will be
      collected from subjects meeting eligibility criteria. Consenting subjects with clinically
      significant screening lab values may be excluded from the study after biomarker sample
      collection (i.e., clinical lab test results will become available after the biomarker sample
      collection). The prescribing of drugs to humans will not be part of this protocol.
    
  